Veeva Systems' stock surged 6.72% in pre-market trading on Monday, following recent announcements of significant enterprise adoption of its cloud platforms within the life sciences industry.

The company recently secured several key wins, including Kindeva Drug Delivery adopting Veeva Quality Cloud and global Veeva Vault CRM commitments from Merck KGaA and Teva Pharmaceuticals to modernize their quality and commercial operations. These deals highlight how Veeva is embedding its cloud and AI-driven platforms deeper into life sciences workflows, spanning manufacturing, R&D, and commercial execution.

These developments reinforce Veeva's investment narrative centered on its vertical cloud and AI products maintaining a central role in how life sciences companies run quality, regulatory, and commercial operations. The expanding enterprise footprint, particularly through Kindeva's adoption of Veeva Quality Cloud, supports the thesis that Veeva is building a deeper enterprise cloud moat in the pharmaceutical sector.